<DOC>
	<DOC>NCT02767089</DOC>
	<brief_summary>The purpose of this study is to further access the utility of biochemical and clinical biomarkers for glucocorticoid-mediated anti-inflammatory effects and safety endpoints against which dissociated agonists of the glucocorticoid receptor (DAGR) will be evaluated in adult healthy volunteers.</brief_summary>
	<brief_title>The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<criteria>Healthy male or females willing to be confined and comply with scheduled visits Women are to be surgically sterile. History of febrile illness within 5 days prior to the first dose Positive urine drug screen Treatment with an investigational product within 30 days prior to the first dose of study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor</keyword>
</DOC>